Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 120 entries
Sorted by: Best Match Show Resources per page
Flipping your writing lessons: Optimizing time in your EFL writing classroom

flipped classroom

Buitrago CR, Díaz J.
GSID: X01nGmIxRwUJ
CR Buitrago, J Díaz - Innovations in flipping the language classroom, 2018 - Springer

This chapter presents the process followed by two University professors in flipping the writing component in a general English as a Foreign Language classroom in Colombia. It …

Mycobacterium avium Complex Osteomyelitis in Persons With Human Immunodeficiency Virus: Case Series and Literature Review.

Open forum infectious diseases

Wood BR, Buitrago MO, Patel S, Hachey DH, Haneuse S, Harrington RD.
PMID: 26180837
Open Forum Infect Dis. 2015 Jun 15;2(3):ofv090. doi: 10.1093/ofid/ofv090. eCollection 2015 Sep.

In persons with advanced immunosuppression, Mycobacterium avium complex (MAC) typically causes disseminated disease with systemic symptoms. We report 2 cases in which MAC caused localized osteomyelitis in human immunodeficiency virus (HIV)-infected individuals on antiretroviral therapy with rising CD4 counts....

Six-month Follow-up of Cervical Composite Restorations Placed With a New Universal Adhesive System: A Randomized Clinical Trial.

Operative dentistry

Lopes LS, Calazans FS, Hidalgo R, Buitrago LL, Gutierrez F, Reis A, Loguercio AD, Barceleiro MO.
PMID: 27379834
Oper Dent. 2016 Sep-Oct;41(5):465-480. doi: 10.2341/15-309-C. Epub 2016 Jul 05.

PURPOSE: The objective of this double-blind, randomized clinical trial was to evaluate the six-month clinical performance of a new universal adhesive (Xeno Select, Dentsply) in noncarious cervical lesions (NCCLs) using two evaluation criteria: World Dental Federation (FDI) and the...

[Affection-based medicine, family medicine, and university].

Medicina clinica

Buitrago F.
PMID: 10680134
Med Clin (Barc). 1999 Dec 04;113(19):757-8.

No abstract available.

Low-temperature catalytic adsorption of NO on activated carbon materials.

Langmuir : the ACS journal of surfaces and colloids

López D, Buitrago R, Sepúlveda-Escribano A, Rodríguez-Reinoso F, Mondragón F.
PMID: 17960942
Langmuir. 2007 Nov 20;23(24):12131-7. doi: 10.1021/la701501q. Epub 2007 Oct 26.

The catalytic adsorption of NO on activated carbon materials provides an appropriated alternative for the control of low-concentration emissions of this air pollutant. The surface complexes formed upon NO adsorption at 30 degrees C were studied by X-ray photoelectron...

Telomerase activity in cervical scrapes of women with high-grade cervical disease: A nested case-control study.

Oncology letters

Molano M, Martín DC, Moreno-Acosta P, Hernández G, Cornall A, Buitrago O, Gamboa O, Garland S, Tabrizi S, Muñoz N.
PMID: 29387223
Oncol Lett. 2018 Jan;15(1):354-360. doi: 10.3892/ol.2017.7324. Epub 2017 Nov 01.

Epidemiological information on telomerase activity (TA) and development of cervical lesions is scarce. A nested case-control study was carried out within a cohort of Colombian women tested for Human Papillomavirus (HPV). Measurement of TA was done in cervical scrapes...

First non-intubated uniportal video-assisted pulmonary lobectomy in America.

Journal of visualized surgery

Buitrago R, Serna A, González-Rivas D, Beltrán R, Palacio CM, Parades P, Beltrán J.
PMID: 29078531
J Vis Surg. 2016 Aug 16;2:144. doi: 10.21037/jovs.2016.08.01. eCollection 2016.

The first video-assisted thoracic lobectomy in non-intubated patient in America was performed on 27

2-Hydroxypyridine-.

ACS medicinal chemistry letters

Haudecoeur R, Carotti M, Gouron A, Maresca M, Buitrago E, Hardré R, Bergantino E, Jamet H, Belle C, Réglier M, Bubacco L, Boumendjel A.
PMID: 28105275
ACS Med Chem Lett. 2016 Nov 17;8(1):55-60. doi: 10.1021/acsmedchemlett.6b00369. eCollection 2017 Jan 12.

With the aim to develop effective and selective human tyrosinase inhibitors, we investigated aurone derivatives whose B-ring was replaced by a non-oxidizable 2-hydroxypyridine-

Abstracts from Hydrocephalus 2016.

Fluids and barriers of the CNS

Adam A, Robison J, Lu J, Jose R, Badran N, Vivas-Buitrago T, Rigamonti D, Sattar A, Omoush O, Hammad M, Dawood M, Maghaslah M, Belcher T, Carson K, Hoffberger J, Jusué Torres I, Foley S, Yasar S, Thai QA, Wemmer J, Klinge P, Al-Mutawa L, Al-Ghamdi H, Carson KA, Asgari M, de Zélicourt D, Kurtcuoglu V, Garnotel S, Salmon S, Balédent O, Lokossou A, Page G, Balardy L, Czosnyka Z, Payoux P, Schmidt EA, Zitoun M, Sevestre MA, Alperin N, Baudracco I, Craven C, Matloob S, Thompson S, Haylock Vize P, Thorne L, Watkins LD, Toma AK, Bechter K, Pong AC, Jugé L, Bilston LE, Cheng S, Bradley W, Hakim F, Ramón JF, Cárdenas MF, Davidson JS, García C, González D, Bermúdez S, Useche N, Mejía JA, Mayorga P, Cruz F, Martinez C, Matiz MC, Vallejo M, Ghotme K, Soto HA, Riveros D, Buitrago A, Mora M, Murcia L, Bermudez S, Cohen D, Dasgupta D, Curtis C, Domínguez L, Remolina AJ, Grijalba MA, Whitehouse KJ, Edwards RJ, Eleftheriou A, Lundin F, Fountas KN, Kapsalaki EZ, Smisson HF, Robinson JS, Fritsch MJ, Arouk W, Garzon M, Kang M, Sandhu K, Baghawatti D, Aquilina K, James G, Thompson D, Gehlen M, Schmid Daners M, Eklund A, Malm J, Gomez D, Guerra M, Jara M, Flores M, Vío K, Moreno I, Rodríguez S, Ortega E, Rodríguez EM, McAllister JP, Guerra MM, Morales DM, Sival D, Jimenez A, Limbrick DD, Ishikawa M, Yamada S, Yamamoto K, Junkkari A, Häyrinen A, Rauramaa T, Sintonen H, Nerg O, Koivisto AM, Roine RP, Viinamäki H, Soininen H, Luikku A, Jääskeläinen JE, Leinonen V, Kehler U, Lilja-Lund O, Kockum K, Larsson EM, Riklund K, Söderström L, Hellström P, Laurell K, Kojoukhova M, Sutela A, Vanninen R, Vanha KI, Timonen M, Rummukainen J, Korhonen V, Helisalmi S, Solje E, Remes AM, Huovinen J, Paananen J, Hiltunen M, Kurki M, Martin B, Loth F, Luciano M, Luikku AJ, Hall A, Herukka SK, Mattila J, Lötjönen J, Alafuzoff I, Jurjević I, Miyajima M, Nakajima M, Murai H, Shin T, Kawaguchi D, Akiba C, Ogino I, Karagiozov K, Arai H, Reis RC, Teixeira MJ, Valêncio CG, da Vigua D, Almeida-Lopes L, Mancini MW, Pinto FCG, Maykot RH, Calia G, Tornai J, Silvestre SSS, Mendes G, Sousa V, Bezerra B, Dutra P, Modesto P, Oliveira MF, Petitto CE, Pulhorn H, Chandran A, McMahon C, Rao AS, Jumaly M, Solomon D, Moghekar A, Relkin N, Hamilton M, Katzen H, Williams M, Bach T, Zuspan S, Holubkov R, Rigamonti A, Clemens G, Sharkey P, Sanyal A, Sankey E, Rigamonti K, Naqvi S, Hung A, Schmidt E, Ory-Magne F, Gantet P, Guenego A, Januel AC, Tall P, Fabre N, Mahieu L, Cognard C, Gray L, Buttner-Ennever JA, Takagi K, Onouchi K, Thompson SD, Thorne LD, Tully HM, Wenger TL, Kukull WA, Doherty D, Dobyns WB, Moran D, Vakili S, Patel MA, Elder B, Goodwin CR, Crawford JA, Pletnikov MV, Xu J, Blitz A, Herzka DA, Guerrero-Cazares H, Quiñones-Hinojosa A, Mori S, Saavedra P, Treviño H, Maitani K, Ziai WC, Eslami V, Nekoovaght-Tak S, Dlugash R, Yenokyan G, McBee N, Hanley DF.
PMID: 28929972
Fluids Barriers CNS. 2017 Jun 07;14:15. doi: 10.1186/s12987-017-0054-5.

No abstract available.

Novel Pure αVβ3 Integrin Antagonists That Do Not Induce Receptor Extension, Prime the Receptor, or Enhance Angiogenesis at Low Concentrations.

ACS pharmacology & translational science

Li J, Fukase Y, Shang Y, Zou W, Muñoz-Félix JM, Buitrago L, van Agthoven J, Zhang Y, Hara R, Tanaka Y, Okamoto R, Yasui T, Nakahata T, Imaeda T, Aso K, Zhou Y, Locuson C, Nesic D, Duggan M, Takagi J, Vaughan RD, Walz T, Hodivala-Dilke K, Teitelbaum SL, Arnaout MA, Filizola M, Foley MA, Coller BS.
PMID: 32259072
ACS Pharmacol Transl Sci. 2019 Aug 02;2(6):387-401. doi: 10.1021/acsptsci.9b00041. eCollection 2019 Dec 13.

The integrin αVβ3 receptor has been implicated in several important diseases, but no antagonists are approved for human therapy. One possible limitation of current small-molecule antagonists is their ability to induce a major conformational change in the receptor that...

Designing an mHealth application to bridge health disparities in Latina breast cancer survivors: a community-supported design approach.

Design for health (Abingdon, England)

Iacobelli F, Adler RF, Buitrago D, Buscemi J, Corden ME, Perez-Tamayo A, Penedo FJ, Rodriguez M, Yanez BR.
PMID: 30506017
Design Health (Abingdon). 2018;2(1):58-76. doi: 10.1080/24735132.2018.1452871. Epub 2018 Apr 02.

Latina breast cancer patients in the USA report significantly worse cancer-related symptom burden and health-related quality of life than non-Hispanic whites. However, health literacy (e.g. knowledge about cancer, coping skills and communication) has been found to improve quality of...

Dialysis Outcomes in a Middle-Income Country: An Updated Comparison of Patient Mortality between Hemodialysis and Peritoneal Dialysis.

Blood purification

Sanabria RM, Vesga JI, Johnson DW, Rivera AS, Buitrago G, Lindholm B, Sanchez R.
PMID: 34903682
Blood Purif. 2021 Dec 10;1-11. doi: 10.1159/000520518. Epub 2021 Dec 10.

INTRODUCTION: Comparisons of survival between dialysis modalities is of great importance to patients with kidney failure, their families, and healthcare systems.OBJECTIVE: This study's objective was to compare mortality of patients on chronic hemodialysis (HD) or peritoneal dialysis (PD) and...

Showing 1 to 12 of 120 entries